Department of Urology, Spedali Civili Hospital, University of Brescia, Brescia, Italy.
Department of Urology, Careggi Hospital, University of Florence, Florence, Italy.
Eur Urol. 2018 Nov;74(5):661-667. doi: 10.1016/j.eururo.2018.07.029. Epub 2018 Aug 10.
The hypothesis that renal function could influence oncological outcomes is supported by anecdotal literature.
To determine whether estimated glomerular filtration rate (eGFR) is related to cancer-specific mortality (CSM) in patients who had undergone surgery for renal cell carcinoma (RCC).
DESIGN, SETTING, AND PARTICIPANTS: A retrospective analysis of 3457 patients who underwent radical (39%) or partial nephrectomy (61%) for cT1-2 RCC between 1990 and 2015.
The eGFR was calculated by the Chronic Kidney Disease Epidemiology Collaboration equation. CSM was analyzed in a multivariable competing-risk framework, estimating the subdistribution hazard ratio (SHR) accounting for deaths from other causes. The relationship between eGFR and CSM was investigated from multiple statistical approaches-extended Cox regression with eGFR incorporated as a time-dependent covariate, landmark analysis, and joint modeling. Other predictors were selected by competing-risk random forest method and backward elimination.
The relationship between eGFR and CSM was graphically described by a linear spline, i.e. a continuous piecewise linear function with two lines joined by a knot. For eGFR treated as a time-dependent covariate, the knot was located at 65ml/min; at landmark analysis with eGFR at the baseline, 12 mo, and last functional follow-up, the knots were 85, 60, and 65ml/min, respectively. In multivariable competing-risk analysis, CSM was associated with eGFR only for values of eGFR below these cutoffs, with SHRs for every 10ml/min of reduction in eGFR of 1.25 (p=0.003), 1.16 (p=0.028), 1.44 (p=0.02), and 1.16 (p=0.042), corresponding to time-dependent eGFR, and eGFR at baseline, 12 mo, and last functional follow-up, respectively. Joint modeling confirmed these results. A retrospective design with inherent biases in data collection represents a limitation.
In patients undergoing surgery for RCC, renal function should be preserved in order to improve cancer-related survival.
The relationship between renal function and probability of dying due to renal cancer is complex. The present study found a correlation between glomerular filtration rate and cancer specific mortality that could reconsider the oncological role of renal function in patients undergoing surgery for renal cancer.
肾功能可能影响肿瘤学结果的假设得到了文献的支持。
确定估算肾小球滤过率(eGFR)与接受肾细胞癌(RCC)手术治疗的患者的癌症特异性死亡率(CSM)是否相关。
设计、地点和参与者:这是一项回顾性分析,共纳入了 1990 年至 2015 年间接受根治性(39%)或部分肾切除术(61%)治疗 cT1-2 RCC 的 3457 例患者。
通过慢性肾脏病流行病学合作方程计算 eGFR。在多变量竞争风险框架中分析 CSM,估计考虑其他原因死亡的亚分布风险比(SHR)。通过多种统计方法研究 eGFR 与 CSM 的关系,包括将 eGFR 作为时变协变量纳入扩展 Cox 回归、 landmark 分析和联合建模。使用竞争风险随机森林方法和后向消除法选择其他预测因子。
通过线性样条图描述 eGFR 与 CSM 之间的关系,即两条线通过一个结连接的连续分段线性函数。对于作为时变协变量的 eGFR,结位于 65ml/min 处;在以 eGFR 为基线、12 个月和最后一次功能随访的 landmark 分析中,结分别位于 85、60 和 65ml/min 处。在多变量竞争风险分析中,仅在 eGFR 值低于这些截止值时,CSM 与 eGFR 相关,eGFR 每降低 10ml/min,SHR 为 1.25(p=0.003)、1.16(p=0.028)、1.44(p=0.02)和 1.16(p=0.042),分别对应于时变 eGFR 以及基线、12 个月和最后一次功能随访时的 eGFR。联合建模证实了这些结果。数据收集存在固有偏倚的回顾性设计是一个局限性。
对于接受 RCC 手术治疗的患者,应保留肾功能以提高癌症相关生存率。
肾功能与因肾癌而死亡的概率之间的关系很复杂。本研究发现肾小球滤过率与癌症特异性死亡率之间存在相关性,这可能会重新考虑肾功能在接受肾细胞癌手术治疗的患者中的肿瘤学作用。